Sector revisions Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.45 USD | +1.49% |
|
-1.34% | -20.12% |
Main competitors
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility (Composite) | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
17 | ||||||||
22 | ||||||||
24 | ||||||||
19 | ||||||||
22 | ||||||||
14 | ||||||||
10 | ||||||||
15 | ||||||||
16 | ||||||||
15 | ||||||||
22 | ||||||||
11 | ||||||||
15 | ||||||||
13 | ||||||||
11 | ||||||||
26 | ||||||||
8 | ||||||||
14 | ||||||||
Average | 16 | |||||||
Weighted average by Cap. | 18 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition